H. Bachelez
Paris Descartes University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by H. Bachelez.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Archier; S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; Pascal Joly; D. Jullien; L. Misery; C. Paul; J.-P. Ortonne; M.-A. Richard
Backgroundu2002 Oral 8‐methoxypsoralen–UV‐A (PUVA) and narrowband UV‐B (NB‐UVB or UVB TL‐01) are effective and widely used treatments for chronic plaque psoriasis. Although the role of PUVA therapy in skin carcinogenesis in humans with psoriasis has been clearly demonstrated, there is still controversy regarding the risk of skin cancer with NB‐UVB. Furthermore, there is no clear evidence about the maximum cumulative number of sessions not to be exceeded in a lifetime.
Journal of The European Academy of Dermatology and Venereology | 2015
Alexander Nast; Paolo Gisondi; A.D. Ormerod; P Saiag; Catherine Smith; Phyllis I. Spuls; Petr Arenberger; H. Bachelez; Jonathan Barker; E. Daudén; E.M.G.J. de Jong; E. Feist; A. Jacobs; Ray Jobling; Lajos Kemény; Mara Maccarone; Ulrich Mrowietz; Kim Papp; C. Paul; Kristian Reich; Stefanie Rosumeck; T. Talme; H.B. Thio; P.C.M. van de Kerkhof; Ricardo Niklas Werner; Nikhil Yawalkar
European S3-Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC A. Nast,* P. Gisondi, A.D. Ormerod, P. Saiag, C. Smith, P.I. Spuls, P. Arenberger, H. Bachelez, J. Barker, E. Dauden, E.M. de Jong, E. Feist, A. Jacobs, R. Jobling, L. Kem eny, M. Maccarone, U. Mrowietz, K.A. Papp, C. Paul, K. Reich, S. Rosumeck, T. Talme, H.B. Thio, P. van de Kerkhof, R.N. Werner, N. Yawalkar Division of Evidence Based Medicine, Department of Dermatology, Charit e – Universit€ atsmedizin Berlin, Berlin, Germany Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK Service de Dermatologie, Hôpital Ambroise Par e Universit e Paris V, Boulogne, France Clinical Lead for Dermatology, St Johns Institute of Dermatology, St Thomas’ Hospital, London, UK Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands Third Faculty of Medicine, Department of Dermatology, Charles University, Prague, Czech Republic Department of Dermatology, Hôpital Saint-Louis, Paris, France St. Johns Institute of Dermatology, St. Thomas’ Hospital, London, UK Hospital Universitario de la Princesa, Madrid, Spain University Medical Center Nijmegen St Radboud, Nijmegen, The Netherlands Medizinische Klinik mit Schwerpunkt Rheumatologie u. klinische Immonologie, Charit e – Universit€atsmedizin Berlin, Berlin, Germany Cambridge, UK SZTE Borgyogyaszati Klinika, Szeged, Hungary Roma, Italy Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany Waterloo, Canada Department of Dermatology, Paul Sabatier University, Toulouse, France Dermatologikum Hamburg, Hamburg, Germany Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden Department of Dermatology, Erasmus University, Rotterdam, The Netherlands Department of Dermatology, University Hospital Nijmegen, Nijmegen, The Netherlands Department of Dermatology, Inselspital, Universit€ atsklinik f€ ur Dermatologie, Bern, Switzerland *Correspondence: A. Nast. E-mail: [email protected] Received: 22 June 2015; Accepted: 7 July 2015
Journal of The European Academy of Dermatology and Venereology | 2012
E. Archier; S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; Pascal Joly; D. Jullien; L. Misery; C. Paul; J.-P. Ortonne; M.-A. Richard
Backgroundu2002 Oral 8‐methoxypsoralen‐UV‐A (PUVA) and Narrowband UV‐B (NB‐UVB or UVB TL‐01) are well established treatments for chronic plaque psoriasis but there is limited evidence regarding their respective efficacy.
Journal of The European Academy of Dermatology and Venereology | 2012
C. Paul; A. Gallini; E. Archier; E. Castela; S. Devaux; S. Aractingi; F. Aubin; H. Bachelez; B. Cribier; Pascal Joly; D. Jullien; M. Le Maître; L. Misery; M.-A. Richard; J.-P. Ortonne
Backgroundu2002 Although topical treatments and phototherapy are available for more than 40u2003years, there is a paucity of evidence‐based recommendations regarding their use.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Castela; E. Archier; S. Devaux; A. Gallini; S. Aractingi; B. Cribier; D. Jullien; F. Aubin; H. Bachelez; Pascal Joly; M. Le Maître; L. Misery; M.-A. Richard; C. Paul; J.-P. Ortonne
Backgroundu2002 Topical steroids have been used for more than 50u2003years in mild‐to‐moderate plaque psoriasis and carry a theoretical risk of adverse events.
Journal of The European Academy of Dermatology and Venereology | 2012
S. Devaux; A. Castela; E. Archier; A. Gallini; Pascal Joly; L. Misery; S. Aractingi; F. Aubin; H. Bachelez; B. Cribier; D. Jullien; M. Le Maître; M.-A. Richard; J.-P. Ortonne; C. Paul
Objectiveu2002 The objective of this systematic review was to prepare for evidence‐based recommendations on the use of vitamin D analogues, and their combination with topical steroids in psoriasis.
British Journal of Dermatology | 2012
A. Maza; M.-A. Richard; F. Aubin; J.-P. Ortonne; S. Prey; H. Bachelez; M. Beylot-Barry; Cristina Bulai-Livideanu; M. Lahfa; J. Nougué; X. Mengual; M. Le Moigne; Valérie Lauwers-Cances; C. Paul
Backgroundu2002 There is a low rate of systemic treatment usage in moderate to severe psoriasis.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Castela; E. Archier; S. Devaux; A. Gallini; S. Aractingi; B. Cribier; D. Jullien; F. Aubin; H. Bachelez; Pascal Joly; M. Le Maître; L. Misery; M.-A. Richard; C. Paul; J.-P. Ortonne
Introductionu2002 Topical steroids are used for more than 50u2003years to treat mild‐to‐moderate plaque psoriasis. The purpose of this systematic review was to evaluate the efficacy but also the optimal modalities of administration of topical corticosteroids in psoriasis i.e. influence of steroid potency on clinical response, putative impact of topical formulation, occlusion procedure, rate of application to control the initial response and the potential interest of a maintenance treatment to prolong psoriasis clearance.
Journal of Investigative Dermatology | 2015
Manuelle Viguier; H. Bachelez; Béatrice Poirier; Jérémy Kagan; Maxime Battistella; F. Aubin; Antoine Touzé; Maryvonnick Carmagnat; C. Francès; Marie-Lise Gougeon; Nicolas Fazilleau
Erosive oral lichen planus (OLP) is a chronic, disabling mucocutaneous dysimmune rare disease characterized by mucosal inflammatory erosive lesions with pathological evidence for a marked CD8+ cytotoxic T-lymphocyte (CTL) infiltration. However, the specificity of lesional CTL in OLP has never been analyzed. To investigate the molecular mechanisms underlying dysregulation of T-cell immune responses in patients with OLP, we studied the diversity and antigen specificity of the TCR expressed by CD8+ T cells using dextramer staining, spectratyping, and TCR sequencing in 10 OLP patients undergoing extracorporeal photochemotherapy. Expansions of TCRVβ3-bearing CD8+ T cells were found in peripheral blood and in lesional tissues of OLP patients. Spectratyping and sequencing studies identified specific clonotypes in each patient. These expansions were enriched with human papillomavirus 16 (HPV16)-specific CD8+ T cells in HLA-A*0201+ patients as shown by their immune recognition of the E711-20 immunodominant epitope. Under treatment with extracorporeal photochemotherapy, clonotypic CD8+ T-cell expansions decreased in parallel with clinical remission. Altogether, these data establish a link between HPV infection and OLP pathogenesis by identifying a massive clonal expansion of CD8+ T cells with increased frequency of HPV 16-specific CD8+ T cells in OLP patients.
Journal of The European Academy of Dermatology and Venereology | 2015
H. Gilet; A. Roborel de Climens; B Arnould; H. Bachelez; M. Bagot; P. Beaulieu; P. Joly; D. Jullien; M. Le Maître; J.-P. Ortonne; C. Paul; E. Thibout
To date, there is no global consensus on the definition of the severity of psoriasis. The REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire has recently been developed to provide a better understanding of plaque‐type psoriasis severity and treatment efficacy from both patient and clinician perspectives.